1naresh
Array
(
    [urn:ac.highwire.org:guest:identity] => Array
        (
            [runtime-id] => urn:ac.highwire.org:guest:identity
            [type] => guest
            [service-id] => ajnr-ac.highwire.org
            [access-type] => Controlled
            [privilege] => Array
                (
                    [urn:ac.highwire.org:guest:privilege] => Array
                        (
                            [runtime-id] => urn:ac.highwire.org:guest:privilege
                            [type] => privilege-set
                            [privilege-set] => GUEST
                        )

                )

            [credentials] => Array
                (
                    [method] => guest
                )

        )

)
1naresh
Array
(
    [urn:ac.highwire.org:guest:identity] => Array
        (
            [runtime-id] => urn:ac.highwire.org:guest:identity
            [type] => guest
            [service-id] => ajnr-ac.highwire.org
            [access-type] => Controlled
            [privilege] => Array
                (
                    [urn:ac.highwire.org:guest:privilege] => Array
                        (
                            [runtime-id] => urn:ac.highwire.org:guest:privilege
                            [type] => privilege-set
                            [privilege-set] => GUEST
                        )

                )

            [credentials] => Array
                (
                    [method] => guest
                )

        )

)


Baseline and Interventional Characteristics
VariablesN = 26a
Baseline
 Age77 (61, 83)
 Sex (male)18 (69%)
 NIHSS on admission15 (11, 20)
Intervention
 eTICI score (core-lab adjudicated grading)
  2a2 (8%)
  2b502 (8%)
  2b6710 (38%)
  2c5 (19%)
  37 (27%)
 Time from DSA to FPCTP (min)4.3 (3.2, 7.5)
 Total contrast dose for both DSA and FPCTP (mL)200 (183, 228)
Outcome
 NIHSS at 24 hours6 (2, 15)
 90-day mRS
  02 (7.7%)
  18 (31%)
  22 (7.7%)
  34 (15%)
  43 (12%)
  51 (3.8%)
  66 (23%)
  • a Data are median (IQR); n (%).